482
M. Juneja et al. / European Journal of Medicinal Chemistry 63 (2013) 474e483
whereas apoptosis results in a loss of mitochondrial membrane
potential and a subsequent green fluorescence. JC-1 was diluted in
medium to a final concentration of 5 mg/mL and the JC-1 containing
medium was added to the treated cells, followed by incubation for
10 min at 37 ꢁC (or RT for 15 min). Subsequently the cells were
washed twice with PBS and analyzed under Nikon Eclipse TS100
inverted fluorescent microscope.
Technology (a), Government of India. Manisha Juneja was a
recipient of MHRD fellowship from IIT Madras. Uma Vanam and
Sripriya Paranthaman were recipients of post-doctoral fellow-
ships from the Department of Biotechnology, Government of India.
Asha Bharathan was a recipient of fellowship from University of
Kerala. Justus K. Reena was a recipient of University Grants Com-
mission (UGC) fellowship. Venugopal S. Keerthi obtained her
research fellowship from Kerala State Council for Science, Tech-
nology and Environment. K.N. Rajasekharan is a recipient of UGC
BSR Faculty Fellowship.
4.8. Flow cytometry
Cells were treated with DIT1e3 or DCT1e2 for 24 h and 48 h. The
cells were then harvested, washed in PBS-EDTA and fixed overnight
in cold 70% ethanol at 4 ꢁC. The cells were then pelleted by
centrifugation, washed twice with PBS-1% FBS, and were resus-
Appendix A. Supplementary data
Supplementary data related to this article can be found at
pended in 300
ml of PBS. 2.5
m
l RNase A (20 mg/mL) was added to it
and incubated at 37 ꢁC for 1 h. This is followed by addition of 3
mL PI
(1 mg/mL) and then cells were analyzed through Cell lab QuantaÔ
SC flow cytometer from Beckman Coulter.
References
[1] T.E. Adrian, Novel marine-derived anti-cancer agents, Curr. Pharm. Des. 13
(2007) 3417e3426.
[2] G. Schwartsmann, Marine organisms and other novel natural sources of new
cancer drugs, Ann. Oncol. 11 (Suppl. 3) (2000) 235e243.
[3] B. Haefner, Drugs from the deep: marine natural products as drug candidates,
Drug Discov. Today 8 (2003) 536e544.
[4] G.M. Cragg, D.J. Newman, K.M. Snader, Natural products in drug discovery and
development, J. Nat. Prod. 60 (1997) 52e60.
4.9. Caspase assays
Activation of Caspases 3, 8 and 9 was assessed by using a fluoro-
genic substrate assay.1 ꢂ106 cells were seeded in a 60 mm Petri dish
and treated with DIT1e3 or DCT1e2 for desired timings. Cells were
lysed in lysis buffer (10 mM TriseHCl, 10 mM NaH2PO4/Na2HPO4, pH
7.5, 130 mM NaCl, 1% Triton-X-100, 10 mM NaPPi). For each reaction
[5] S. Urban, S.J.H. Hickford, J.W. Blunt, M.H.G. Munro, Bioactive marine alkaloids,
Curr. Org. Chem. (2000) 765e807.
[6] K.B. Glaser, A.M. Mayer, A renaissance in marine pharmacology: from pre-
clinical curiosity to clinical reality, Biochem. Pharmacol. 78 (2009) 440e448.
[7] T.F. Molinski, D.S. Dalisay, S.L. Lievens, J.P. Saludes, Drug development from
marine natural products, Nat. Rev. Drug Discov. 8 (2009) 69e85.
[8] G. Schwartsmann, A.B. Da Rocha, J. Mattei, R. Lopes, Marine-derived
anticancer agents in clinical trials, Exp. Opin. Investig. Drugs 12 (2003)
1367e1383.
[9] R. Singh, M. Sharma, P. Joshi, D.S. Rawat, Clinical status of anti-cancer agents
derived from marine sources, Anticancer Agents Med. Chem. 8 (2008) 603e617.
[10] J.W. Blunt, B.R. Copp, M.H.G. Munro, P.T. Northcote, M.R. Prinsep, Marine
natural products, Nat. Prod. Rep. 23 (2006) 26e78.
or time point, 5
well containing 50
10 mMDTT,1 mM EDTA, 0.1%CHAPS,10%sucrose, pH7.2). 50
m
l reconstituted caspase substrate was added to each
L of 2ꢂ assay buffer (20 mM PIPES,100 mM NaCl,
L ofcell
m
m
lysate was added to each well/reaction and incubated for 1 h at 37 ꢁC.
The amount of AFC liberated was read using a plate reader (Spec-
traMax) with excitation wavelength of 400 nm and an emission
wavelength of 480e520 nm. Caspase activation was expressed in
relative fluorescence units in folds over the untreated control.
[11] U. Pindur, T. Lemster, Advances in marine natural products of the indole and
annelated indole series: chemical and biological aspects, Curr. Med. Chem. 8
(2001) 1681e1698.
4.10. Transient transfection and luciferase assay
[12] J. Kobayashi, T. Murayama, M. Ishibashi, S. Kosuge, M. Takamatsu, Y. Ohizumi,
H. Kobayashi, T. Ohta, S. Nozoe, T. Sasaki, Hyrtiosins A and B, new indole al-
kaloids from the Okinawan marine sponge Hyrtios erecta, Tetrahedron 46
(1990) 7699e7702.
[13] S. Kohmoto, Y. Kashman, O.J. McConnell, K.L. Rinehart, A. .Wright, F. .Koehn,
Dragmacidin, a new cytotoxic bis(indole) alkaloid from a deep water marine
sponge, Dragmacidon sp, J. Org. Chem. 53 (1988) 3116e3118.
[14] A.E. Wright, S.A. Pomponi, S.S. Cross, P. McCarthy, A new bis(indole) alkaloid
from a deep-water marine sponge of the genus Spongosorites, J. Org. Chem.
57 (1992) 4772e4775.
HeLa cells were seeded at 60% confluency per well in 96 well
plates. After overnight culture, the cells in each well were trans-
fected with 0.2
mg DNA consisting of NF-kB-luciferase reporter
plasmid and renilla luciferase plasmid as internal control (pGL4,
Promega) using lipofectamine reagent (Invitrogen). After 24 h of
transfection, the cells were incubated in medium containing DIT1e
3 or DCT1e2 or DMSO (control) for 24 h and then treated with TNF-
a
(20 ng/ml) for 5 h. The cells were harvested and luciferase assay
[15] S. Tsujii, K.L. Rinehart, S.P. Gunasekera, Y. Kashman, S.S. Cross, M.S. Lui,
S.A.
Pomponi,
M.C.
Diaz,
Topsentin,
bromotopsentin,
and
was performed using dual-luciferase assay kit (Promega), according
to the manufacturer’s protocol. The luminescence was measured
using Spectramax-L luminometer, Molecular Devices, USA. Results
were normalized with internal control plasmid and expressed as
relative luminescence units in fold over control.
dihydrodeoxybromo-topsentin: antiviral and antitumor bis-(indolyl)imidaz-
oles from Caribbean deep-sea sponges of the family halichondriidae, J. Org.
Chem. 53 (1988) 5446e5453.
[16] K. Bartik, J.C. Braekman, D. Daloze, C. Stoller, J. Huysecom, G. Vandevyver,
R. Ottinger, Topsentins, new toxic bisindole alkaloids from the marine sponge
Topsentia genitrix, Can. J. Chem. 65 (1987) 2118e2121.
[17] S. Sakemi, H.H. Sun, Nortopsentins A, B, and C. Cytotoxic and antifungal
imidazolediylbis[indoles] from the sponge Spongosorites ruetzleri, J. Org.
Chem. 56 (1991) 4304e4307.
4.11. Statistical significance
[18] B. Jiang, X.H. Gu, Syntheses and cytotoxicity evaluation of bis(indolyl)thiazole,
bis(indolyl)pyrazinone and bis(indolyl)pyrazine: analogues of cytotoxic ma-
rine bis(indole) alkaloid, Bioorg. Med. Chem. 2 (2000) 363e371.
[19] X.H. Gu, X.Z. Wan, B. Jiang, Syntheses and biological activities of bis(3-indolyl)
thiazoles, analogues of marine bis(indole)alkaloid nortopsentins, Bioorg. Med.
Chem. Lett. 9 (1999) 569e572.
[20] W.N. Xiong, C.G. Yang, B. Jiang, Synthesis of novel analogues of marine indole
alkaloids: mono(indolyl)-4-trifluoromethylpyridines and bis(indolyl)-4-
trifluoromethylpyridines as potential anticancer agents, Bioorg. Med. Chem.
9 (2001) 1773e1780.
[21] S.K.C. Devi, Chemistry and Bioactivity of Compounds from Marine Organisms
and Their Analogs, Ph.D. dissertation, Univ. of Kerala, India, Nov 1999.
[22] T.F.A.F. Reji, K.N. Rajasekharan, Synthesis of 3-(2,4-diaminothiazol-5-oyl)in-
doles, J. Saudi Chem. Soc. 12 (2008) 269e274.
[23] K.G. Sreejalekshmi, S.K.C. Devi, K.N. Rajasekharan, An efficient protocol for
solid phase aminothiazole synthesis, Tetrahedron Lett. 47 (2006) 6179e6182.
Statistical significance was evaluated using Graphpad Prism
software. All the data were expressed as mean ꢀ SD and P value
<0.05 was considered significant.
Conflicts of interest
The authors declare that there are no conflicts of interest.
Acknowledgment
The authors are thankful to the financial support by the
Department of Biotechnology and Department of Science and